Definitive Contract HHSN261201000099C

Ended Awarded Last action

Contract number
HHSN261201000099C
Awardee
Awarding agency
Obligated
$797,705

Award facts

Opportunity
Contract value 35% obligated
  • $797,705.20 Current, with exercised options
  • $2,277,241.20 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Frederick, MD 21701, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00021 $51,518
Funding Only Action P00020 $32,825
Other Administrative Action 19 -$6,589
Funding Only Action 18 · Pathology and veterinary support for preclinical toxicology studies purpose: to deobligate the expiring fiscal year 2012 funded lines as indicated on page 2… -$34,542
Funding Only Action 17 · Purpose: to deobligate the expiring fiscal year 2011 funded line item 2 in the amount of $45,857.16. The total paid, on line item 2 is $128,831.84, out of the… -$45,857
Funding Only Action 16 · Pathology and veterinary support for preclinical toxicology studies -$34,377
Exercise an Option 15 · MOD #15 exercises option 2A in a reduced amount of $53,210 period of performance: 09/30/2010 - 09/29/2013 $53,210
Other Administrative Action 14 · This modification revises the header text information added in MOD#13. $0
Other Administrative Action 13 · This modification restructures the contract, removing work assignments, and creating additional options. $0
Other Administrative Action 12 · Other functions this modification restructures the contract, removing work assignments, and creating additional options. $0
Funding Only Action 11 · Other functions this modification provides an increment of funding to cover work assignment 7 to cover changes requested by C.O.R. From through 9/29/13. $8,028
Exercise an Option 10 · Other functions this modification exercise option 2, and provides an increment of funding to cover work assignments 9, 10, and 11 from 9/30/12 through 9/29/13. $98,345
Funding Only Action 9 · Other functions this modification provides funding to cover work assignment 8, and revise sections b, g, and i. $8,906
Funding Only Action 8 · Other functions; , this modification provides funding to cover tissue cross-reactivity study oulined in work assignment 7, MOD 1. $5,084
Other Administrative Action 7 · Other functions , this modification replaces funding to cover continued performance through september, 2012 of work assignment 6. $0
Funding Only Action 6 · Other functions , this modification provides funding to cover continued performance through september, 2012 of work assignment 6. $13,762
Funding Only Action 5 · Other functions , this modification provides funding to cover performance through september, 2012 of work assignment 7. $40,000
Funding Only Action 4 · , this modification provides funding to cover performance through september, 2011 of work assignment 6 MOD 1; and correct error on MOD 3. $10,966
Funding Only Action 3 · , this modification provides funding for to cover performance through november 22, 2012 of work assignment 6. $2,000
Exercise an Option 2 · , exercise of option 1, providing funding for repository work. $174,689
Other Administrative Action 1 · , pathology and veterinary support for toxicology studies $0
Original award $419,737
Show all 22

About this award

Written by GovTribe AI ·

This is a federal contract awarded by the National Cancer Institute (NCI), a civilian agency, to Charles River Laboratories, Inc. (Charles River), a for-profit organization and manufacturer. The contract, valued at $2,277,241.20, is a definitive, cost-plus-fixed-fee contract with a completion date of September 29, 2013. The contract does not have a set-aside designation.

The award indicates that Charles River provides a wide range of research-related products and services to government agencies, including laboratory animals, diagnostic testing, virus vaccines, cell banks, and other materials critical for biomedical research and public health initiatives. Charles River has been awarded numerous prime and subcontracts by federal agencies to support their research and development efforts. This contract with NCI is likely part of the company's longstanding role in supplying specialized research products and services to government agencies.

Quick answers

Who was awarded contract HHSN261201000099C?

HHSN261201000099C was awarded to Charles River Laboratories, Inc. by National Cancer Institute (National Institutes of Health) on September 30, 2010.

How much is contract HHSN261201000099C worth?

The government has obligated $797,705 on HHSN261201000099C. Its potential value, with all options, is $2,277,241.

Was contract HHSN261201000099C competed?

The extent of competition for HHSN261201000099C was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login